Lab in a Pill

submit enquiry
Lab In A Pill
Lab In A Pill

University: University of Glasgow

Sector(s): Life Sciences

About Opportunity:

In the western world, colorectal cancer is now the third most frequent cancer and the second most common cause of cancer deaths. In the US nearly 150,000 new cases are being diagnosed each year and more than 56,000 people died from the disease in 2002. In the UK, around 15,000 people die from the disease each year.

Current screening techniques are notoriously inaccurate, leading to many false positives which saturate resources available for follow-up diagnosis. But scientists at the University of Glasgow have pioneered a new sensor technology, Lab-in-a-Pill, that could have major impact on the cost and effectiveness of bowel cancer treatment. At the core of Lab-in-a-Pill is a miniaturised sensor, processing and communications module all enclosed in a chemical-resistant capsule which currently measures around 3cm x 1cm in prototype form. This sensor wirelessly transmits data to a receiver pack worn on the outside of the body. The device has been taken to laboratory-scale. Prototyping of devices and in-vivo trials remain to be completed.

Key Benefits:

  • Improved compliance and screening response rate with elimination of sample collection 
  • Reduced false positives and improved sensitivity through measurement at the source of bleeding

Applications:

  • The Lab-in-a-Pill technology has been designed to be used in healthcare screening.

IP Status:

The IP associated with this technology is owned by the University of Glasgow.

Enquiry

Please enter your name.

Please enter the name of the company you work for.

Is your company an SME?

Please select the country you are in.

Please select what part of the UK you are in.

Please select from the following options.

Please enter your email address.

To help us process your enquiry faster please enter some details about the information you are interested in.

Words remaining:

Related Opportunities

  • Thermoelectric Sensor

    The Thermoelectric Sensor technology is a Nano-Calorimetric Sensor which measures very small changes in temperature. The IP provides a route to making the most sensitive calorimetric measurements (with a resolution of 0.1 mK).

    Expires: Created:
  • Parkinson's Disease Model

    The University of Glasgow is offering an exciting new model for the evaluation of new treatments for Parkinsons disease

    Expires: Created:
  • Combination Treatment for MRSA Nasal Carriage and MRSA-infected Wounds

    The new treatment is a combination of a peptide (ranalexin) with bacteria cell wall-digesting protein (lysostaphin), which specifically targets and kills Staphylococcus aureus, including MRSA.

    Expires: Created:
  • Synergistic antifungal combination

    Candida species are a major cause of catheter-related nosocomial bloodstream infections. We have identified that the combination of an echinocandin antifungal with certain antimicrobial peptides results in potent, synergistic inhibition of yeast pathogens in vitro, so offering a potential combinatio...

    Expires: Created:
  • Biocatalysis of a novel fluorinated sugar [18-F]-FDR for PET imaging

    Combining the sequential use of 2 enzymes – fluorinase and nucleoside hydrolase – we have successfully produced a new radiotracer with potential as an imaging biomarker for PET scans. The fluorinase enzyme combines fluorine with S-adenosyl-L-methionine (SAM) to generate 5'-fluro-5'-deoxy...

    Expires: Created:

Alerts Signup

Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities


Register Now for University Technology.com Alerts


Search Filter

Share this page

Use the buttons below to share these technology opportunities on your favourite social networking site. You can also share them from inside the individual opportunity.